» Articles » PMID: 22563393

Bronchial Responsiveness is Related to Increased Exhaled NO (FE(NO)) in Non-smokers and Decreased FE(NO) in Smokers

Overview
Journal PLoS One
Date 2012 May 8
PMID 22563393
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Both atopy and smoking are known to be associated with increased bronchial responsiveness. Fraction of nitric oxide (NO) in the exhaled air (FE(NO)), a marker of airways inflammation, is decreased by smoking and increased by atopy. NO has also a physiological bronchodilating and bronchoprotective role.

Objectives: To investigate how the relation between FE(NO) and bronchial responsiveness is modulated by atopy and smoking habits.

Methods: Exhaled NO measurements and methacholine challenge were performed in 468 subjects from the random sample of three European Community Respiratory Health Survey II centers: Turin (Italy), Gothenburg and Uppsala (both Sweden). Atopy status was defined by using specific IgE measurements while smoking status was questionnaire-assessed.

Main Results: Increased bronchial responsiveness was associated with increased FE(NO) levels in non-smokers (p = 0.02) and decreased FE(NO) levels in current smokers (p = 0.03). The negative association between bronchial responsiveness and FE(NO) was seen only in the group smoking less <10 cigarettes/day (p = 0.008). Increased bronchial responsiveness was associated with increased FE(NO) in atopic subjects (p = 0.04) while no significant association was found in non-atopic participants. The reported interaction between FE(NO) and smoking and atopy, respectively were maintained after adjusting for possible confounders (p-values<0.05).

Conclusions: The present study highlights the interactions of the relationship between FE(NO) and bronchial responsiveness with smoking and atopy, suggesting different mechanisms behind atopy- and smoking-related increases of bronchial responsiveness.

Citing Articles

[Effects of type 2 inflammation on bronchodilator responsiveness of large and small airways in chronic obstructive pulmonary disease].

Xu G, Gong Z, Wang J, Ma Y, Xu M, Chen M Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(1):93-99.

PMID: 38293980 PMC: 10878905. DOI: 10.12122/j.issn.1673-4254.2024.01.11.

References
1.
Laprise C, Laviolette M, Boutet M, Boulet L . Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J. 1999; 14(1):63-73. DOI: 10.1034/j.1399-3003.1999.14a12.x. View

2.
Emms J, Rogers D . Cigarette smoke-inhibition of neurogenic bronchoconstriction in guinea-pigs in vivo: involvement of exogenous and endogenous nitric oxide. Br J Pharmacol. 1998; 122(4):779-85. PMC: 1564994. DOI: 10.1038/sj.bjp.0701440. View

3.
Hessel E, Cruikshank W, Van Ark I, De Bie J, Van Esch B, Hofman G . Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol. 1998; 160(6):2998-3005. View

4.
Chinn S, Burney P, Jarvis D, Luczynska C . Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1998; 10(11):2495-501. DOI: 10.1183/09031936.97.10112495. View

5.
Malinovschi A, Janson C, Hogman M, Rolla G, Toren K, Norback D . Both allergic and nonallergic asthma are associated with increased FE(NO) levels, but only in never-smokers. Allergy. 2008; 64(1):55-61. DOI: 10.1111/j.1398-9995.2008.01835.x. View